Hepatitis C, Chronic
Showing 1 - 25 of 338
Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)
Recruiting
- Chronic Hepatitis C Virus
- +4 more
-
Bucuresti, BUC, RomaniaAtea Study Site
Jun 15, 2023
Population in Improving Eearly Diagnosis Efficancy in Chinese
Recruiting
- Carcinoma, Hepatocellular
- +4 more
- Liver cancer surveillance every 3 months
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023
Occult Hepatitis C Virus Infection in Patients Born Before 1969
Not yet recruiting
- Hepatitis C, Chronic
- +2 more
- Meridan Bioscience Point of Care test against HCV antibodies
- (no location specified)
Apr 2, 2023
Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney
Recruiting
- Diabetes Mellitus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)
Recruiting
- Hepatitis C, Chronic
- Pregnancy; Infection
- Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
-
Denver, Colorado
- +4 more
Dec 3, 2022
Hepatitis C, Chronic Trial in Carlsbad (ISIS 14803)
Completed
- Hepatitis C, Chronic
- ISIS 14803
-
Carlsbad, CaliforniaIsis Pharmaceuticals
Dec 1, 2022
Hepatitis C, Chronic Trial in United States (ISIS 14803, peginterferon alfa, ribavirin)
Completed
- Hepatitis C, Chronic
- ISIS 14803, peginterferon alfa, ribavirin
-
Birmingham, Alabama
- +24 more
Dec 1, 2022
Hepatitis C, Chronic Trial in Albuquerque (HCV RNA screening)
Terminated
- Hepatitis C, Chronic
- HCV RNA screening
-
Albuquerque, New Mexico
- +1 more
Oct 26, 2022
Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)
Recruiting
- Liver Cirrhosis
- +2 more
- Prolonged-Release Pirfenidone
-
Guadalajara, Jalisco, Mexico
- +1 more
Sep 13, 2022
Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)
Completed
- Hepatitis C, Chronic
- Opioid-use Disorder
-
Pittsburgh, PennsylvaniaMagee Womens Hospital of UPMC
Aug 19, 2022
Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)
Active, not recruiting
- Hepatitis C, Chronic
- Opioid Dependence, on Agonist Therapy
- Health care delivery
-
Bergen, Hordaland, Norway
- +1 more
Aug 5, 2022
Eliminating HCV Infection Among PWUD
Recruiting
- Hepatitis C, Chronic
- Drug Use
-
Vancouver, British Columbia, CanadaVancouver Infectious Diseases Centre
Jul 22, 2022
Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)
Recruiting
- Hepatitis C, Chronic
- P1101 + Ribavirin
-
Chiayi City, Taiwan
- +7 more
Jun 30, 2022
Evaluating the Chain of Addiction Care (CAC)
Recruiting
- Hepatitis C, Chronic
- Substance Use Disorders
-
Nijmegen, Gelderland, NetherlandsRadboudumc
May 31, 2022
Hepatitis C, Chronic, Substance Use Disorders Trial in Roanoke (Peer specialist (PS) and vouchers)
Not yet recruiting
- Hepatitis C, Chronic
- Substance Use Disorders
- Peer specialist (PS) and vouchers
-
Roanoke, VirginiaCarilion Clinic
May 25, 2022
Possible Differences in HCC Course Depending on DAA Treatment
Recruiting
- Carcinoma, Hepatocellular
- +5 more
- Direct Acting Antivirals
-
Warsaw, Mazowieckie, PolandMedical University of Warsaw
May 11, 2022
Hepatitis C, Hepatitis C, Chronic Trial in Australia (Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay)
Not yet recruiting
- Hepatitis C
- Hepatitis C, Chronic
- Xpert HCV Viral Load Fingerstick
- Aptima HCV Quant DX Assay
-
Canberra, Australian Capital Territory, Australia
- +21 more
Mar 30, 2022
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic
Active, not recruiting
- Hepatitis C, Chronic
- GeneXpert HCV VL Fingerstick test
-
Bruxelles, BelgiumCHU Saint-Pierre
Feb 8, 2022
Chronic Hepatitis c After Treatment With Direct Action
Completed
- Hepatitis C, Chronic
-
Sevilla, SpainHospital Universitario Virgen macarena
Nov 15, 2021
Hepatitis C, Chronic Trial in Mansoura (Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet)
Completed
- Hepatitis C, Chronic
- Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet
-
Mansoura, EgyptMansoura University Children Hospital
Oct 21, 2021
Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)
Completed
- Hepatitis C, Chronic
- PEGASYS 180 µg Q1W
- +3 more
-
Changhua, Taiwan
- +12 more
Oct 7, 2021
Multidisciplinary Support Program in Chronic Hepatitis C
Completed
- Hepatitis C, Chronic
- Multidisciplinary support program
-
Barcelona, SpainHospital del Mar
Sep 15, 2021
Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)
Recruiting
- Hepatitis C, Chronic
- Sofosbuvir-Velpatasvir Drug Combination
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh, Magee Womens Hospital
Sep 3, 2021
Health Literacy and HCV Knowledge on HCV Treatment Willingness
Completed
- Hepatitis C
- +2 more
-
San Diego, CaliforniaOwen Clinic - University of California, San Diego
Sep 1, 2021
DAA Uptake in Controlling HCV Epidemic and Modeling
Recruiting
- Hepatitis C
- +2 more
-
San Diego, CaliforniaOwen Clinic-University of California, San Diego
Sep 1, 2021